Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Pharmacogenomics
|
April 16, 2019
<i>CYP2C19</i> genotype, physician prescribing pattern, and risk for long QT on serotonin selective reuptake inhibitors
Natasha Petry, Roxana Lupu, Ahmed Gohar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2002
Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy
Michael P Dubé, Dajun Qian, Hannah Edmondson-Melançon, et al.
Brain Injury
|
July 1, 2006
Establishing a prognosis for functional outcome during coma recovery
Theresa Louise-Bender Pape, Sandra Lundgren, Allen W Heinemann, et al.
Journal of Patient-Centered Research and Reviews
|
January 30, 2023
Impact of Perioperative Dexamethasone on Hospital Length of Stay and Glycemic Control in Patients With Type 2 Diabetes Undergoing Total Hip Arthroplasty
Vanessa Williams, Mohammad J Uddin Ansari, Amruta Jaju, et al.
Diabetologia
|
May 10, 2015
Deletion of the gene for adiponectin accelerates diabetic nephropathy in the Ins2 (+/C96Y) mouse
Fei Fang, Eun-Hui Bae, Amanda Hu, et al.
Plos One
|
August 17, 2013
Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury
Fei Fang, George Chu Liu, Xiaohua Zhou, et al.
The American Journal of Pathology
|
March 18, 2015
Characterization of the intrarenal renin-angiotensin system in experimental alport syndrome
Eun Hui Bae, Ana Konvalinka, Fei Fang, et al.
Hematological Oncology
|
July 27, 2023
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL-102): A phase 1 study
Mehdi Hamadani, Morton Coleman, Ralph Boccia, et al.
The Lancet. Oncology
|
September 18, 2015
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study
Marinus H J van Oers, Kazimierz Kuliczkowski, Lukáš Smolej, et al.
British Journal of Haematology
|
April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients
Anders Österborg, William G Wierda, Jiří Mayer, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Pharmacogenomics
|
April 16, 2019
<i>CYP2C19</i> genotype, physician prescribing pattern, and risk for long QT on serotonin selective reuptake inhibitors
Natasha Petry, Roxana Lupu, Ahmed Gohar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2002
Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy
Michael P Dubé, Dajun Qian, Hannah Edmondson-Melançon, et al.
Brain Injury
|
July 1, 2006
Establishing a prognosis for functional outcome during coma recovery
Theresa Louise-Bender Pape, Sandra Lundgren, Allen W Heinemann, et al.
Journal of Patient-Centered Research and Reviews
|
January 30, 2023
Impact of Perioperative Dexamethasone on Hospital Length of Stay and Glycemic Control in Patients With Type 2 Diabetes Undergoing Total Hip Arthroplasty
Vanessa Williams, Mohammad J Uddin Ansari, Amruta Jaju, et al.
Diabetologia
|
May 10, 2015
Deletion of the gene for adiponectin accelerates diabetic nephropathy in the Ins2 (+/C96Y) mouse
Fei Fang, Eun-Hui Bae, Amanda Hu, et al.
Plos One
|
August 17, 2013
Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury
Fei Fang, George Chu Liu, Xiaohua Zhou, et al.
The American Journal of Pathology
|
March 18, 2015
Characterization of the intrarenal renin-angiotensin system in experimental alport syndrome
Eun Hui Bae, Ana Konvalinka, Fei Fang, et al.
Hematological Oncology
|
July 27, 2023
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL-102): A phase 1 study
Mehdi Hamadani, Morton Coleman, Ralph Boccia, et al.
The Lancet. Oncology
|
September 18, 2015
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study
Marinus H J van Oers, Kazimierz Kuliczkowski, Lukáš Smolej, et al.
British Journal of Haematology
|
April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients
Anders Österborg, William G Wierda, Jiří Mayer, et al.
Page
of 2